IGHE and Tumor Lysis Syndrome: Multiple mechanisms, including acute anaphylactic (IgE-mediated) and anaphylactoid responses to the mAb, serum sickness, tumor lysis syndrome (TLS), and cytokine release syndrome (CRS), might result in acute reactions after mAb infusion resulting in clinical symptoms.